News

Metastatic Prostate Cancer Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...
New cell signaling pathway found to shield blood vessels from hypertension damage
By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of ...
AI-designed inhibitor targets key enzyme to fight prostate cancer drug resistance
Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...
The Malaysian Reserve2d
RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...
Renal & Urology News2d
Cabozantinib Plus Atezolizumab Appears More Effective Than Switching ARPIs in mCRPC
The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.
The University of Alabama at Birmingham6d
Scientists uncover new approach for targeting aggressive breast cancer
In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...